Vical - 26 Year Stock Price History | VICL

Historical daily share price chart and data for Vical since 1993 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Vical as of February 15, 2019 is 0.99.
Vical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 1.0048 1.1650 1.1800 0.9048 0.9900 -16.10%
2018 1.4128 1.8800 1.9000 1.0000 1.1800 -35.52%
2017 2.2905 2.3700 2.9700 1.6600 1.8300 -20.43%
2016 3.5848 4.5300 4.7200 2.2300 2.3000 -43.90%
2015 7.5560 10.7000 14.8000 3.5000 4.1000 -60.95%
2014 12.4050 11.9000 17.2000 10.0000 10.5000 -11.02%
2013 26.4965 30.9000 42.6000 10.1500 11.8000 -59.45%
2012 33.8280 44.9000 45.8000 27.4000 29.1000 -34.01%
2011 33.3924 20.7000 52.0000 17.4000 44.1000 118.32%
2010 30.0867 34.1000 40.1000 18.1000 20.2000 -38.60%
2009 27.6742 14.1000 53.6000 13.5000 32.9000 133.33%
2008 29.1989 43.4000 43.4000 11.0000 14.1000 -66.82%
2007 51.2621 64.3000 68.4000 40.7000 42.5000 -33.90%
2006 54.8608 42.6000 74.5000 40.5000 64.3000 53.10%
2005 46.6385 47.0000 60.5000 35.0000 42.0000 -10.64%
2004 53.5763 49.9000 81.0000 41.7000 47.0000 -4.47%
2003 43.0587 32.4900 67.2000 22.3000 49.2000 41.79%
2002 65.4546 121.2000 123.3000 23.1000 34.7000 -71.65%
2001 130.0886 178.8000 196.9000 86.0000 122.4000 -33.84%
2000 264.3802 300.6000 690.0000 143.8000 185.0000 -38.21%
1999 141.4521 151.3000 299.4000 95.6300 299.4000 110.99%
1998 144.0550 121.3000 184.4000 73.7500 141.9000 18.25%
1997 139.0877 167.5000 181.3000 97.5000 120.0000 -27.27%
1996 152.7123 122.5000 212.5000 110.0000 165.0000 36.03%
1995 92.0298 77.5000 135.0000 65.0000 121.3000 47.03%
1994 103.3347 150.0000 160.0000 68.7500 82.5000 -38.89%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.021B $0.014B
Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.167B 12.95
Gilead Sciences (GILD) United States $85.858B 10.77
Biogen (BIIB) United States $63.873B 12.38
Celgene (CELG) United States $63.569B 11.78
Vertex Pharmaceuticals (VRTX) United States $47.481B 63.60
Regeneron Pharmaceuticals (REGN) United States $45.346B 21.06
Illumina (ILMN) United States $42.993B 51.13
Alexion Pharmaceuticals (ALXN) United States $28.142B 17.44
Incyte (INCY) United States $17.752B 166.84
BioMarin Pharmaceutical (BMRN) United States $16.643B 0.00
Seattle Genetics (SGEN) United States $11.010B 0.00
Exact Sciences (EXAS) United States $10.830B 0.00
Sarepta Therapeutics (SRPT) United States $9.013B 0.00
QIAGEN (QGEN) Netherlands $8.716B 28.50
Alnylam Pharmaceuticals (ALNY) United States $8.401B 0.00
BeiGene (BGNE) Cayman Islands $8.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.748B 49.54
Bluebird Bio (BLUE) United States $7.345B 0.00
Bio-Techne Corp (TECH) United States $7.121B 47.98
Exelixis (EXEL) United States $6.667B 15.59
Moderna (MRNA) United States $6.467B 0.00
Amarin (AMRN) Ireland $5.603B 0.00
Galapagos (GLPG) Belgium $5.280B 0.00
Alkermes (ALKS) Ireland $5.050B 0.00
Array BioPharma (ARRY) United States $4.809B 0.00
Guardant Health (GH) United States $4.191B 0.00
Horizon Pharma Public (HZNP) Ireland $3.844B 15.81
Allogene Therapeutics (ALLO) United States $3.783B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.759B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.424B 0.00
Emergent Biosolutions (EBS) United States $3.312B 27.90
Intercept Pharmaceuticals (ICPT) United States $3.298B 0.00
Blueprint Medicines (BPMC) United States $3.276B 0.00
Ascendis Pharma (ASND) Denmark $2.965B 0.00
Genomic Health (GHDX) United States $2.945B 99.42
Ultragenyx Pharmaceutical (RARE) United States $2.805B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.743B 0.00
China Biologic Products (CBPO) China $2.688B 19.13
Immunomedics (IMMU) United States $2.668B 0.00
Global Blood Therapeutics (GBT) United States $2.640B 0.00
Repligen (RGEN) United States $2.580B 80.57
Ligand Pharmaceuticals (LGND) United States $2.569B 18.45
Reata Pharmaceuticals (RETA) United States $2.559B 0.00
Mirati Therapeutics (MRTX) United States $2.504B 0.00
Akcea Therapeutics (AKCA) United States $2.399B 0.00
Halozyme Therapeutics (HALO) United States $2.391B 53.35
Arena Pharmaceuticals (ARNA) United States $2.379B 0.00
Myriad Genetics (MYGN) United States $2.265B 23.07
Amicus Therapeutics (FOLD) United States $2.122B 0.00
Insmed (INSM) United States $2.012B 0.00
Acceleron Pharma (XLRN) United States $1.929B 0.00
Denali Therapeutics (DNLI) United States $1.924B 0.00
Spark Therapeutics (ONCE) United States $1.910B 0.00
AnaptysBio (ANAB) United States $1.851B 0.00
Atara Biotherapeutics (ATRA) United States $1.800B 0.00
Medicines (MDCO) United States $1.773B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.770B 0.00
MyoKardia (MYOK) United States $1.691B 0.00
REGENXBIO (RGNX) United States $1.666B 22.34
NeoGenomics (NEO) United States $1.629B 134.08
CRISPR Therapeutics AG (CRSP) Switzerland $1.605B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.600B 0.00
Myovant Sciences (MYOV) United Kingdom $1.522B 0.00
Innoviva (INVA) United States $1.488B 4.10
Allakos (ALLK) United States $1.485B 0.00
Aimmune Therapeutics (AIMT) United States $1.385B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.360B 0.00
Clovis Oncology (CLVS) United States $1.343B 0.00
UniQure (QURE) Netherlands $1.341B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.237B 0.00
Lion Biotechnologies (IOVA) United States $1.217B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.210B 0.00
Cambrex (CBM) United States $1.201B 12.97
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.182B 0.00
Codexis (CDXS) United States $1.177B 0.00
Rubius Therapeutics (RUBY) United States $1.083B 0.00
WAVE Life Sciences (WVE) Singapore $1.076B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.055B 42.81
Deciphera Pharmaceuticals (DCPH) United States $1.053B 0.00
Puma Biotechnology (PBYI) United States $1.035B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.022B 0.00
Audentes Therapeutics (BOLD) United States $1.021B 0.00
Epizyme (EPZM) United States $0.987B 0.00
Coherus BioSciences (CHRS) United States $0.965B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.964B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.955B 0.00
Editas Medicine (EDIT) United States $0.950B 0.00
Fate Therapeutics (FATE) United States $0.948B 0.00
Sangamo Therapeutics (SGMO) United States $0.919B 0.00
Retrophin (RTRX) United States $0.881B 0.00
Novavax (NVAX) United States $0.842B 0.00
Athenex (ATNX) United States $0.836B 0.00
Vericel (VCEL) United States $0.833B 0.00
CytomX Therapeutics (CTMX) United States $0.832B 0.00
Apellis Pharmaceuticals (APLS) United States $0.799B 0.00
G1 THERAPEUTICS (GTHX) United States $0.779B 0.00
Intra-Cellular Therapies (ITCI) United States $0.745B 0.00
Heska (HSKA) United States $0.741B 60.67
Acorda Therapeutics (ACOR) United States $0.740B 9.60
Y-mAbs Therapeutics (YMAB) United States $0.732B 0.00
InflaRx (IFRX) Germany $0.729B 0.00
Arvinas (ARVN) United States $0.727B 0.00
Cellectis (CLLS) France $0.711B 0.00
Principia Biopharma (PRNB) United States $0.698B 0.00
ANI Pharmaceuticals (ANIP) United States $0.698B 13.34
Dicerna Pharmaceuticals (DRNA) United States $0.672B 0.00
Dynavax Technologies (DVAX) United States $0.661B 0.00
Revance Therapeutics (RVNC) United States $0.659B 0.00
RA PHARMCTL INC (RARX) United States $0.659B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.655B 0.00
Cara Therapeutics (CARA) United States $0.650B 0.00
Viking Therapeutics (VKTX) United States $0.647B 0.00
Twist Bioscience (TWST) United States $0.628B 0.00
Intellia Therapeutics (NTLA) United States $0.603B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.564B 0.00
UROGEN PHARMA (URGN) Israel $0.557B 0.00
Anika Therapeutics (ANIK) United States $0.555B 22.98
Kura Oncology (KURA) United States $0.551B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.550B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.542B 0.00
Osiris Therapeutics (OSIR) United States $0.525B 0.00
Eidos Therapeutics (EIDX) United States $0.517B 0.00
Prothena (PRTA) Ireland $0.508B 0.00
Zymeworks (ZYME) Canada $0.496B 0.00
Arcus Biosciences (RCUS) United States $0.478B 0.00
Synthorx (THOR) United States $0.477B 0.00
UNITY Biotechnology (UBX) $0.476B 0.00
PDL BioPharma (PDLI) United States $0.472B 7.69
DBV Technologies (DBVT) France $0.467B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.457B 0.00
Zealand Pharma (ZEAL) Denmark $0.452B 4.98
Clementia Pharmaceuticals (CMTA) Canada $0.444B 0.00
ObsEva SA (OBSV) Switzerland $0.436B 0.00
Agenus (AGEN) United States $0.425B 0.00
Replimune (REPL) United States $0.424B 0.00
Senesco Technologies (ELOX) United States $0.419B 0.00
Cytokineticsorporated (CYTK) United States $0.417B 0.00
Scholar Rock Holding (SRRK) United States $0.416B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.414B 0.00
Five Prime Therapeutics (FPRX) United States $0.408B 0.00
BeyondSpring (BYSI) United States $0.404B 0.00
Mesoblast (MESO) Australia $0.398B 0.00
OSMOTICA PHARM (OSMT) United States $0.394B 0.00
Kezar Life Sciences (KZR) United States $0.388B 0.00
Sinovac Biotech (SVA) China $0.379B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.366B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.360B 0.00
Kindred Biosciences (KIN) United States $0.355B 0.00
Stemline Therapeutics (STML) United States $0.353B 0.00
Inovio Pharmaceuticals (INO) United States $0.352B 0.00
AVROBIO (AVRO) United States $0.352B 0.00
Cellular Biomedicine (CBMG) United States $0.350B 0.00
MeiraGTx Holdings (MGTX) United States $0.349B 0.00
Gritstone Oncology (GRTS) United States $0.327B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.326B 0.00
Krystal Biotech (KRYS) United States $0.321B 0.00
Urovant Sciences (UROV) United States $0.318B 0.00
BioDelivery Sciences (BDSI) United States $0.318B 0.00
XBiotech (XBIT) United States $0.315B 0.00
Abeona Therapeutics (ABEO) United States $0.312B 0.00
Albireo Pharma (ALBO) United States $0.309B 0.00
Evelo Biosciences (EVLO) United States $0.305B 0.00
Gamida Cell (GMDA) Israel $0.304B 0.00
Enochian BioSciences (ENOB) United States $0.299B 0.00
Constellation Pharmaceuticals (CNST) United States $0.292B 0.00
Aduro Biotech (ADRO) United States $0.292B 0.00
MediciNova (MNOV) United States $0.288B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.283B 0.00
Magenta Therapeutics (MGTA) United States $0.279B 0.00
Sorrento Therapeutics (SRNE) United States $0.276B 0.00
Solid Biosciences (SLDB) United States $0.275B 0.00
Axsome Therapeutics (AXSM) United States $0.273B 0.00
Merus (MRUS) Netherlands $0.272B 0.00
Intec Pharma (NTEC) Israel $0.265B 0.00
Geron (GERN) United States $0.265B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.258B 0.00
Liquidia Technologies (LQDA) United States $0.257B 0.00
AC Immune SA (ACIU) Switzerland $0.257B 0.00
Kadmon Holdings (KDMN) United States $0.256B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.254B 0.00
Kodiak Sciences (KOD) United States $0.249B 0.00
Kala Pharmaceuticals (KALA) United States $0.244B 0.00
Seres Therapeutics (MCRB) United States $0.239B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.231B 0.00
Celcuity (CELC) United States $0.229B 0.00
Synlogic (SYBX) United States $0.228B 0.00
Verastem (VSTM) United States $0.227B 0.00
Kamada (KMDA) Israel $0.227B 10.26
ResTORbio (TORC) United States $0.224B 0.00
MannKind (MNKD) United States $0.222B 0.00
Sutro Biopharma (STRO) United States $0.221B 0.00
Adverum Biotechnologies (ADVM) United States $0.220B 0.00
Strongbridge Biopharma (SBBP) United States $0.220B 0.00
Syros Pharmaceuticals (SYRS) United States $0.219B 0.00
TOCAGEN INC (TOCA) United States $0.216B 0.00
Athersys (ATHX) United States $0.213B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.208B 0.00
Arbutus Biopharma (ABUS) Canada $0.205B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.202B 0.00
LogicBio Therapeutics (LOGC) United States $0.202B 0.00
Celyad SA (CYAD) Belgium $0.199B 0.00
ChromaDex (CDXC) United States $0.197B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.196B 0.00
Compugen (CGEN) Israel $0.192B 0.00
Aptinyx (APTX) United States $0.191B 0.00
CorMedix Inc (CRMD) United States $0.187B 0.00
Cerecor (CERC) United States $0.184B 0.00
Protagonist Therapeutics (PTGX) United States $0.179B 0.00
Spero Therapeutics (SPRO) United States $0.178B 0.00
ADMA Biologics Inc (ADMA) United States $0.177B 0.00
Enzo Biochem (ENZ) United States $0.170B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.168B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
VBI Vaccines (VBIV) United States $0.160B 0.00
Palatin Technologies (PTN) United States $0.159B 78.29
Menlo Therapeutics (MNLO) United States $0.155B 0.00
BioXcel Therapeutics (BTAI) United States $0.155B 0.00
Proteostasis Therapeutics (PTI) United States $0.152B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.151B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.150B 0.00
Mersana Therapeutics (MRSN) United States $0.147B 0.00
OvaScience (MLND) United States $0.147B 0.00
BioTime (BTX) United States $0.146B 0.00
Allena Pharmaceuticals (ALNA) United States $0.144B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.141B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.139B 0.00
Cohbar (CWBR) United States $0.129B 0.00
Unum Therapeutics (UMRX) United States $0.128B 0.00
Checkpoint Therapeutics (CKPT) United States $0.128B 0.00
Trevena (TRVN) United States $0.128B 0.00
Organovo Holdings (ONVO) United States $0.127B 0.00
Cue Biopharma (CUE) United States $0.126B 0.00
Pfenex (PFNX) United States $0.123B 0.00
Fortress Biotech (FBIO) United States $0.123B 0.00
Anavex Life Sciences (AVXL) United States $0.121B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.120B 0.00
Mustang Bio (MBIO) United States $0.118B 0.00
Pluristem Therapeutics (PSTI) Israel $0.117B 0.00
XOMA (XOMA) United States $0.117B 0.00
Eton Pharmaceuticals (ETON) United States $0.115B 0.00
Equillium (EQ) United States $0.113B 0.00
Oncobiologics (OTLK) United States $0.109B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
VolitionRX (VNRX) Singapore $0.101B 0.00
VTv Therapeutics (VTVT) United States $0.100B 0.00
Catalyst Biosciences (CBIO) United States $0.100B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.097B 0.00
Chiasma (CHMA) United States $0.092B 0.00
Neothetics (EVFM) United States $0.091B 0.00
Signal Genetics (MGEN) United States $0.090B 0.00
NantKwest (NK) United States $0.087B 0.00
Cel-Sci (CVM) United States $0.083B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Cocrystal Pharma (COCP) United States $0.080B 88.67
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.079B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.078B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.076B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.076B 0.00
Alimera Sciences (ALIM) United States $0.076B 0.00
Provention Bio (PRVB) United States $0.075B 0.00
Orgenesis (ORGS) United States $0.075B 0.00
PHASEBIO PHARMA (PHAS) United States $0.074B 0.00
Aptose Biosciences (APTO) Canada $0.071B 0.00
Idera Pharmaceuticals (IDRA) United States $0.071B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Cidara Therapeutics (CDTX) United States $0.069B 0.00
Protalix BioTherapeutics (PLX) Israel $0.067B 0.00
AEterna Zentaris (AEZS) United States $0.066B 12.63
SESEN BIO, INC (SESN) United States $0.061B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.060B 0.00
Celldex Therapeutics (CLDX) United States $0.059B 0.00
Eyenovia (EYEN) United States $0.059B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
Ophthotech (OPHT) United States $0.059B 0.00
Evogene (EVGN) Israel $0.058B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.057B 0.00
ScPharmaceuticals (SCPH) United States $0.057B 0.00
Proteon Therapeutics (PRTO) United States $0.057B 0.00
OVID THERAPEUTC (OVID) United States $0.057B 0.00
Vaccinex (VCNX) United States $0.056B 0.00
VIVUS (VVUS) United States $0.055B 0.00
NewLink Genetics (NLNK) United States $0.055B 0.00
Entera Bio (ENTX) Israel $0.054B 0.00
Alcobra (ARCT) United States $0.053B 0.00
ARAVIVE, INC (ARAV) United States $0.053B 4.61
VistaGen Therapeutics (VTGN) United States $0.052B 0.00
Clearside Biomedical (CLSD) United States $0.050B 0.00
Asterias Biotherapeutics (AST) United States $0.049B 0.00
Bellerophon Therapeutics (BLPH) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Selecta Biosciences (SELB) United States $0.043B 0.00
Bionano Genomics (BNGO) United States $0.043B 0.00
Motif Bio Plc (MTFB) United States $0.042B 0.00
Celsion (CLSN) United States $0.041B 0.00
OncoSec Medical (ONCS) United States $0.040B 0.00
Moleculin Biotech (MBRX) United States $0.040B 0.00
Arsanis (ASNS) United States $0.040B 0.00
Caladrius Biosciences (CLBS) United States $0.039B 0.00
DiaMedica Therapeutics (DMAC) United States $0.038B 0.00
Aptevo Therapeutics (APVO) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Curis (CRIS) United States $0.034B 0.00
Sophiris Bio (SPHS) United States $0.034B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.032B 0.00
Galena Biopharma (SLS) United States $0.032B 0.00
Adial Pharmaceuticals (ADIL) United States $0.031B 0.00
AZURRX BIOPHARM (AZRX) United States $0.030B 0.00
TRACON Pharmaceuticals (TCON) United States $0.030B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.030B 4.81
IMMURON LTD (IMRN) Australia $0.029B 0.00
Advaxis (ADXS) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.028B 0.00
Oragenics (OGEN) United States $0.027B 0.00
Zosano Pharma (ZSAN) United States $0.026B 0.00
Novelion Therapeutics (NVLN) Canada $0.026B 0.00
Apricus Biosciences (SEEL) United States $0.024B 0.00
GENPREX INC (GNPX) United States $0.023B 0.00
GTx (GTXI) United States $0.023B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.022B 0.00
BioPharmX (BPMX) United States $0.022B 0.00
Fibrocell Science Inc (FCSC) United States $0.021B 0.00
Benitec Biopharma (BNTC) Australia $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
CytRx (CYTR) United States $0.020B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.020B 0.00
IBio (IBIO) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Soligenix (SNGX) United States $0.015B 0.00
ATyr Pharma (LIFE) United States $0.015B 0.00
Prana Biotechnology (PRAN) Australia $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.014B 6.93
Genetic Technologies (GENE) Australia $0.014B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Aytu Bioscience (AYTU) United States $0.013B 0.00
Edge Therapeutics (EDGE) United States $0.013B 0.00
Hemispherx BioPharma (HEB) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Vital Therapies (VTL) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Histogenics (HSGX) United States $0.008B 0.00
RestorGenex (DFFN) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00